Trial intelligence / Profile preview

TEA Trial – Tolerance and Effect of Antipsychotics in Children and Adolescents with Psychosis

2009-016715-38Phase 4Completed

Sponsor
University of Copenhagen
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in schizophrenia, brief psychotic disorder (BPD), schizoaffective disorder and 5 more comparing Quetiapine extended release with Aripiprazole (2 arms). Primary endpoint: Psychopathology – PANSS positive scale. Started Jan 2010; status: completed.

02

Drugs

quetiapinearipiprazole
03

Conditions

schizophreniabrief psychotic disorder (BPD)schizoaffective disorderdelusional disorderpsychosis

Beyond the preview

Go deeper on 2009-016715-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016715-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call